These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4763514)

  • 41. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Adjuvant local BCG-immunotherapy in patients with urothel cancer of the bladder (author's transl)].
    Flamm J; Grof F
    Wien Med Wochenschr; 1981 Oct; 131(20):501-6. PubMed ID: 7314632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cobalt therapy prophylaxis of recurrence of T1 bladder cancer.
    Pow-Sang J; Zaharia M; Ramirez G; Garcia J; Benavente V; Gonzales J
    Prog Clin Biol Res; 1984; 162B():33-7. PubMed ID: 6504903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin reactivity to bacterial antigens in Hodgkin's disease.
    Rasiewicz W; Kardaszewicz E
    Pol Med J; 1969; 8(5):1203-8. PubMed ID: 5383935
    [No Abstract]   [Full Text] [Related]  

  • 46. Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder.
    Kibar Y; Goktas S; Kilic S; Yaman H; Onguru O; Peker AF
    Ann Clin Lab Sci; 2006; 36(1):31-8. PubMed ID: 16501234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The delayed hypersensitivity response: application in clinical surgery.
    Pietsch JB; Meakins JL; MacLean LD
    Surgery; 1977 Sep; 82(3):349-55. PubMed ID: 888102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preliminary studies on human "transfer factor" activity in guinea pigs. Systemic transfer of cutaneous delayed-type hypersensitivity to PPD and SKSD.
    Welch TM; Triglia R; Spitler LE; Fudenberg HH
    Clin Immunol Immunopathol; 1976 May; 5(3):407-15. PubMed ID: 1277593
    [No Abstract]   [Full Text] [Related]  

  • 49. [Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence].
    Chen L; Wang X; Mei H; Chen W
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):484-6. PubMed ID: 11825447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [RBC and T lymphocyte subsets in patients with bladder carcinoma: immunological study].
    Xu J; Zhang Y
    Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):113-6. PubMed ID: 11829798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ageing, immune response, and mortality.
    Roberts-Thomson IC; Whittingham S; Youngchaiyud U; Mackay IR
    Lancet; 1974 Aug; 2(7877):368-70. PubMed ID: 4136513
    [No Abstract]   [Full Text] [Related]  

  • 52. [Characteristics of recurrence of T1G3 transitional cell carcinoma of bladder].
    Zhang YS; Li HZ; Zhang RQ; Shi BB
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1305-8. PubMed ID: 16796897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Whole bladder wall laser irradiation to prevent bladder cancer recurrence with intravesical HpD and ascorbic acid].
    Li C; Chen Y; Wang Q
    Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):463-5. PubMed ID: 10920885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation in vivo, with delayed hypersensitivity skin tests, of cell mediated immunity in patients with severe obesity].
    Adami GF; Griffanti Bartoli F; Traverso E; Scopinaro N
    Minerva Med; 1980 Jun; 71(25):1769-72. PubMed ID: 7413106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case of bullous pemphigoid and transitional cell carcinoma of the bladder. Demonstration of a circulating factor reactive with basement membrane zone of skin and of bladder carcinoma.
    Tanaka T; Ogino A; Ogura K; Nakagawa K
    Arch Dermatol; 1983 Aug; 119(8):704-5. PubMed ID: 6347090
    [No Abstract]   [Full Text] [Related]  

  • 58. [Our experience in treating patients with surface cancer of the bladder].
    Matveev BP; Figurin KM; Romanov VA; Cheban NL
    Urol Nefrol (Mosk); 1995; (5):35-8. PubMed ID: 8571484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of aging and acute illness on delayed hypersensitivity.
    Grossman J; Baum J; Gluckman J; Fusner J; Condemi JJ
    J Allergy Clin Immunol; 1975 Apr; 55(4):268-75. PubMed ID: 235584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.